Global Vaccine Market Forecast

About This Presentation
Title:

Global Vaccine Market Forecast

Description:

For more Info: According to Renub Research latest report on Vaccine industry Global Vaccine Market around the world would be US$ 70 Billion by the year 2024. Vaccine is considered as one of the best quality science across all streams pertinent in the field of Vaccinology. Vaccines are derived from the killed or inactivated pathogens, which are unable to cause any sickness to vaccinated people. When a person is vaccinated, it is impracticable for them to become sick with that particular disease. Early vaccination and the completion of complete vaccination schedule among the infants to their adulthood, helps reduce the prevalence of vaccine preventable diseases and its burden across the countries around the world. – PowerPoint PPT presentation

Number of Views:5

less

Transcript and Presenter's Notes

Title: Global Vaccine Market Forecast


1
Global Vaccine Market and Forecast
Category Vaccines Market Research Report
2
Global Vaccine Market and Forecast Analyst View
Global Vaccine Market is projected to reach US
70 Billion by the year 2024. Get Free
Customization in this Report Press Release Title
Global Vaccine Market predicted to be US 70
Billion by 2024 For more Info  https//www.renu
b.com/global-vaccines-market-to-be-an-opportunity-
of-more-than-us-60-billion-58-nd.php

3
Global Vaccine Market predicted to be US 70
Billion by 2024
Research Report Title Global Vaccine Market,
People Vaccinated, Vaccines Administered,
Immunization, By Disease Influenza, Cervical
Cancer, Zoster (Shingles), MMR (Measles, Mumps,
and Rubella), Pneumonia, Meningitis, Hepatitis,
Tap (Diphtheria, Tetanus, Pertussis), Haemophilus
influenzae type B (Hib), Polio, Rotavirus,
Varicella, Combination Vaccine, Travel
Miscellaneous Vaccine, By End User Infants
(Pediatric), Adult, Companies
(GlaxoSmithKline, Merck, Sanofi, Pfizer,
Others) Access Full Research  https//www.renub.
com/global-vaccines-market-and-forecast-14-vaccine
s-market-number-of-people-immunized-doses-of-vacci
nes-administered-1200-p.php According to Renub
Research latest report on Vaccine industry Global
Vaccine Market around the world would be US 70
Billion by the year 2024. Vaccine is considered
as one of the best quality science across all
streams pertinent in the field of Vaccinology.
Vaccines are derived from the killed or
inactivated pathogens, which are unable to cause
any sickness to vaccinated people.

4
Global Vaccine Market predicted to be US 70
Billion by 2024
Today, vaccination has helped to reduce the
global burden of a range of viral and bacterial
diseases around the world. Vaccination against
the particular disease not only limits the
incidence of that disease, but it also minimizes
the socioeconomic burden of that disease in the
society. An appropriate rate of immunization can
lead to the substantial blocking of transmission
for several vaccine preventable diseases. Today,
the world has witnessed the eradication of
smallpox and is near to the elimination of polio
from most countries across the world due to the
role of immunization in controlling
disease.   List of some of the vaccine
Preventable diseases include   
 Diphtheria     Pertussis (whooping cough)  
 MMR     Polio (poliomyelitis)  
 Hib     Influenza    Hepatitis   
 Pneumococcal infections    Meningococcal
disease     Varicella-zoster     Human
papillomavirus       Tetanus    Yellow
fever     Japanese encephalitis

5
Global Vaccine Market predicted to be US 70
Billion by 2024

6
Global Vaccine Market predicted to be US 70
Billion by 2024
How do Vaccines Work? Vaccines work is to prime
ones immune system against future attacks by a
specific disease. There are vaccines that work
against both bacterial and viral pathogens and
disease causing agents. When a pathogen enters in
the immunized persons body, the persons immune
system generates antibodies to fight it off.
Depending upon the strength of ones immune
response and how effectively the antibodies scrap
off the pathogen, one may or may not get
ill.   Client can Purchase this Report
in Sections from below link  Access full
Research https//www.renub.com/global-vaccines-m
arket-and-forecast-14-vaccines-market-number-of-pe
ople-immunized-doses-of-vaccines-administered-1200
-p.php  

7
Global Vaccine Market is projected to reach US
70 Billion by the year 2024.
When a person is vaccinated with whatever the
version of a pathogen that vaccine contains, the
vaccination isnt so strong to make them sick,
but it has enough for ones immune system to
develop resistance against the particular
pathogen. As a result, the person gets future
immunity against the disease without getting ill
if when exposed to the pathogen. Today, with
increasing community awareness regarding the
benefits of vaccines against vaccine preventable
diseases, increasing government role in
strengthening immunization programs and
increasing funding from several governments and
non-governments sectors certainly help boost
Global Vaccines Market in the near future. 

8
Table of Contents for Global Vaccine Market
Forecast
Key Topics Covered 1.    Research Findings 2.  
 Global Vaccines Market and Forecast 2.1  
 Adult Vaccines Market 2.2    Pediatric (Infant)
Vaccines Market 3.    Global Adult Vaccine vs.
Pediatric Vaccine Market Share 4.    Global
Vaccines Market Share and Forecast 4.1    Adult
Vaccines Market Share 4.2    Pediatric (Infant)
Vaccines Market Share 5.    Global Vaccinated
People 5.1    Adult Immunized and Forecast 5.2  
 Vaccinated Infant (Pediatric) 6.    Global
Vaccinated People Share 6.1    Vaccinated Adult
Share 6.2    Vaccinated Infant (Pediatric) Share

9
Table of Contents for Global Vaccine Market
Forecast
7.    Global Doses of Vaccines Administered and
Forecast 7.1    Doses of Adult Vaccines
Administered 7.2    Doses of Infant (Pediatric)
Vaccines Administered 8.    Global Doses of
Vaccines Administered Share 8.1    Doses of
Vaccines Administered to Adult Share8.2    Doses
of Vaccines Administered to Infant (Pediatric)
Share 9.    Global Vaccine Companies Market
Share and Forecast 10.    Disease wise
Vaccines Market and Forecast 10.1  
 Influenza 10.2    Cervical Cancer (HPV)
10.3    Zoster (Shingles) 10.4    MMR 10.5  
 Pneumococcal 10.6    Meningococcal 10.7  
 Hepatitis 10.8    TdaP and DTaP 10.9  
 Travel and Miscellaneous 10.10    Haemophilus
Influenzae Type B 10.11    Combos (Combination)
10.12    Polio 10.13    Rotavirus 10.14  
 Varicella

10
Table of Contents for Global Vaccine Market
Forecast
11.    Disease wise Numbers of Vaccinated
People Forecast 11.1    Influenza 11.2  
 Cervical Cancer (HPV) 11.3    Zoster
(Shingles) 11.4    MMR 11.5  
 Pneumococcal 11.6    Meningococcal 11.7  
 Hepatitis 11.8    TdaP and DTaP 11.9    Hib
(Haemophilus Influenzae Type B) 11.10    Combos
(Combination Vaccines) 11.11    Polio 11.12  
 Rotavirus 11.13    Varicella 12.    Disease
wise Doses of Vaccines Administered and
Forecast 12.1 Influenza 12.2 Cervical
Cancer (HPV) 12.3 Zoster (Shingles) 12.4
MMR 12.5 Pneumococcal 12.6
Meningococcal 12.7 Hepatitis 12.8 TdaP
and DTaP 12.9 Hib (Haemophilus Influenzae Type
B) 12.10 Polio 12.11 Rotavirus 12.12
Varicella 13.    Disease wise - Immunization
Profile 13.1    Immunization Coverage () in
Infants 13.2    Global Immunization
Profile 13.3    Regional Immunization Profile

11
Table of Contents for Global Vaccine Market
Forecast
14.    Vaccines Key Players Sales and
Forecast 14.1    GlaxoSmithKline, plc.s Vaccines
Sales 14.2    Merck Co. Vaccines Sales 14.3  
 Sanofi Pasteurs Vaccines Sales 14.4    Pfizer,
Inc.s Vaccines Sales 14.5    Global Other
Companies Vaccines Sales 15.    Vaccines
Products and Pipeline 15.1    GSK Vaccine Product
Pipeline 15.2    Merck Vaccine Product
Pipeline 15.3    Sanofi Vaccine Product
Pipeline 15.4    Pfizer Vaccine Product
Pipeline 16.    Top Mergers and Acquisitions in
the Vaccine Industry 17.    Vaccines and
Regulators Interventions 17.1    Making and
Meeting Standards of Quality and Safety 17.2  
 Vaccine Funding

12
Table of Contents for Global Vaccine Market
Forecast
18.    Vaccine Market Drivers 18.1    Inclusion
in National Immunization Schedule 18.2    Growing
Immunization Coverage for HPV Vaccines 18.3  
 Increase in Prevalence of Infectious
Diseases 18.4    Global Immunization Vision and
Strategy (GIVS) 18.5    GAVI Model Fuelling
Vaccine Manufacturers 18.6    Increasing Vaccine
Availability in United States 18.7    The Vaccine
Safety Data link Project 18.8    The Vaccine
Injury Compensation Program 18.9    Transforming
of Vaccine Technologies 18.10    Global Vaccine
Action Plan by WHO (2011 - 2020) 18.11  
 Continuous Focus on Effective Communication
Strategies   19.    Vaccines Market
Challenges 19.1    Hurdles to Optimal use of
Licensed Vaccines 19.2    Complexity of Vaccine
Development Approval System Thwarts
Product 19.3    Shortening the Timeline for
Vaccine Development 19.4    Refusal/Resistance to
Vaccination 19.5    Vaccine Shortages and
Delays 19.6    Obstacles in Vaccine Research
Development 19.7    Barriers to New Entrants in
the Vaccines Market

13
Get Free Customization in this Report

Vaccines Market Reports https//www.renub.com/va
ccines-12-c.php
Renub Research - North America Rajat Gupta 225 Kristie Ln, Roswell Georgia 30076, United States Tel 1-678-302-0700 Email info_at_renub.com www.renub.com Renub Research - Asia Ankit Mishra C 86, Sector 10 Noida 201301, India Tel 91-120-421-9822 Email info_at_renub.com www.renub.com
Write a Comment
User Comments (0)